Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETLAS: Tadalafil in Lacunar Stroke and Cerebral Small Vessel Disease
NCT02801032Phase 2Completed
- Start
- Nov 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in lacunar stroke (LACI), Cerebral Small Vessel Disease (CSVD). Started Nov 2016; status: completed.
02
Drugs
tadalafil
03
Conditions
lacunar stroke (LACI)Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on NCT02801032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02801032.